MX2021000965A - Composiciones que comprenden polirribonucleotidos circulares y usos de estas. - Google Patents
Composiciones que comprenden polirribonucleotidos circulares y usos de estas.Info
- Publication number
- MX2021000965A MX2021000965A MX2021000965A MX2021000965A MX2021000965A MX 2021000965 A MX2021000965 A MX 2021000965A MX 2021000965 A MX2021000965 A MX 2021000965A MX 2021000965 A MX2021000965 A MX 2021000965A MX 2021000965 A MX2021000965 A MX 2021000965A
- Authority
- MX
- Mexico
- Prior art keywords
- compositions
- circular polyribonucleotides
- polyribonucleotides
- circular
- preparations
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/111—General methods applicable to biologically active non-coding nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/13—Decoys
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/15—Nucleic acids forming more than 2 strands, e.g. TFOs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/16—Aptamers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/50—Physical structure
- C12N2310/51—Physical structure in polymeric form, e.g. multimers, concatemers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/50—Physical structure
- C12N2310/53—Physical structure partially self-complementary or closed
- C12N2310/532—Closed or circular
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Virology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862702714P | 2018-07-24 | 2018-07-24 | |
| US201962823569P | 2019-03-25 | 2019-03-25 | |
| US201962863670P | 2019-06-19 | 2019-06-19 | |
| PCT/US2019/043272 WO2020023655A1 (en) | 2018-07-24 | 2019-07-24 | Compositions comprising circular polyribonucleotides and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2021000965A true MX2021000965A (es) | 2021-06-15 |
Family
ID=69182387
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2021000965A MX2021000965A (es) | 2018-07-24 | 2019-07-24 | Composiciones que comprenden polirribonucleotidos circulares y usos de estas. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20210292761A1 (https=) |
| EP (1) | EP3827084A4 (https=) |
| JP (2) | JP2021531022A (https=) |
| KR (1) | KR102950624B1 (https=) |
| CN (1) | CN112567038A (https=) |
| AU (2) | AU2019312269A1 (https=) |
| BR (1) | BR112021001343A2 (https=) |
| CA (1) | CA3107683A1 (https=) |
| IL (1) | IL280354A (https=) |
| MX (1) | MX2021000965A (https=) |
| SG (1) | SG11202100750XA (https=) |
| WO (1) | WO2020023655A1 (https=) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017222911A1 (en) | 2016-06-20 | 2017-12-28 | The Board Of Trustees Of The Leland Stanford Junior University | Circular rnas and their use in immunomodulation |
| CN110612353A (zh) | 2017-03-03 | 2019-12-24 | 加利福尼亚大学董事会 | 经由抑制性tRNAs和脱氨酶对突变进行RNA靶向 |
| CN111819185A (zh) | 2017-12-15 | 2020-10-23 | 旗舰创业创新第六有限责任公司 | 包含环状多核糖核苷酸的组合物及其用途 |
| WO2020198403A2 (en) * | 2019-03-25 | 2020-10-01 | Flagship Pioneering Innovations Vi, Llc | Compositions comprising modified circular polyribonucleotides and uses thereof |
| US20220288176A1 (en) * | 2019-08-28 | 2022-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Circular rna modification and methods of use |
| AU2020395113A1 (en) | 2019-12-02 | 2022-06-09 | Shape Therapeutics Inc. | Therapeutic editing |
| CN115361954A (zh) | 2020-01-29 | 2022-11-18 | 旗舰创业创新第六有限责任公司 | 用于翻译的组合物及其使用方法 |
| CN111500681A (zh) * | 2020-03-20 | 2020-08-07 | 青岛大学 | 用于检测piRNA与mRNA结合的可视化方法及其应用 |
| US20230203192A1 (en) * | 2020-05-20 | 2023-06-29 | Flagship Pioneering, Inc. | Compositions and methods for producing human polyclonal antibodies |
| KR20230028375A (ko) | 2020-06-25 | 2023-02-28 | 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 | 원형 rna 번역을 구동하는 유전 요소와 이를 사용하는 방법 |
| AU2021300378A1 (en) * | 2020-07-01 | 2023-01-19 | Elevatebio Technologies, Inc. | Compositions and methods for cellular reprogramming using circular RNA |
| CN113249811B (zh) * | 2021-05-13 | 2022-11-08 | 太原理工大学 | 一种中空纳米纤维内部固定化生物酶的制备方法 |
| US20240240218A1 (en) | 2021-05-18 | 2024-07-18 | Flagship Pioneering Innovations Vi, Llc | Methods of enriching for circular polyribonucleotides |
| US20240240219A1 (en) | 2021-05-18 | 2024-07-18 | Flagship Pioneering Innovations Vi, Llc | Methods of enriching for circular polyribonucleotides |
| AU2022285744A1 (en) * | 2021-06-02 | 2023-12-14 | Beam Therapeutics Inc. | Circular guide rnas for crispr/cas editing systems |
| CA3219570A1 (en) * | 2021-06-25 | 2022-12-29 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for improved protein translation from recombinant circular rnas |
| CN113264842B (zh) | 2021-07-21 | 2022-03-01 | 苏州科锐迈德生物医药科技有限公司 | 一种脂质化合物及包含其的脂质载体、核酸脂质纳米粒组合物和药物制剂 |
| US20250002898A1 (en) | 2021-07-27 | 2025-01-02 | Flagship Pioneering Innovations Vi, Llc | Devices, systems and methods for processing |
| CN114591986A (zh) * | 2021-07-29 | 2022-06-07 | 苏州科锐迈德生物医药科技有限公司 | 环状rna分子及其在目标蛋白的靶向降解中的应用 |
| MX2024003262A (es) | 2021-09-17 | 2024-06-19 | Flagship Pioneering Innovations Vi Llc | Composiciones y metodos para producir poliribonucleotidos circulares. |
| CN116103284B (zh) * | 2021-11-09 | 2025-09-23 | 中国科学院天津工业生物技术研究所 | 环形gRNA及其相关生物材料与应用 |
| KR20240118174A (ko) | 2021-12-17 | 2024-08-02 | 플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 | 변성 조건 하에서의 원형 rna의 풍부화를 위한 방법 |
| CN121057577A (zh) | 2023-01-27 | 2025-12-02 | 赛欧生物医药股份有限公司 | 经修饰的脂质组合物及其用途 |
| WO2025127854A1 (ko) * | 2023-12-14 | 2025-06-19 | 한국과학기술원 | Circular rna를 이용한 표적 mrna 발현 저해 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPR604101A0 (en) * | 2001-06-29 | 2001-07-26 | Unisearch Limited | Aptamers |
| AU2006275579B2 (en) * | 2005-08-01 | 2012-10-04 | Purdue Research Foundation | Multivalent RNA nanoparticles for delivery of active agents to a cell |
| US20110065086A1 (en) | 2008-02-21 | 2011-03-17 | Otc Biotechnologies, Llc | Methods of producing homogeneous plastic-adherent aptamer-magnetic bead-fluorophore and other sandwich assays |
| AU2013266968B2 (en) * | 2012-05-25 | 2017-06-29 | Emmanuelle CHARPENTIER | Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription |
| CN120574876A (zh) | 2013-08-22 | 2025-09-02 | 纳幕尔杜邦公司 | 使用向导rna/cas内切核酸酶系统的植物基因组修饰及其使用方法 |
| JP7106461B2 (ja) * | 2016-06-07 | 2022-07-26 | セファイド | 熱安定性ポリメラーゼ阻害剤組成物及び方法 |
| WO2020257730A1 (en) * | 2019-06-19 | 2020-12-24 | Flagship Pioneering Innovations Vi, Llc | Compositions comprising circular polyribonucleotides for protein modulation and uses thereof |
-
2019
- 2019-07-24 WO PCT/US2019/043272 patent/WO2020023655A1/en not_active Ceased
- 2019-07-24 MX MX2021000965A patent/MX2021000965A/es unknown
- 2019-07-24 BR BR112021001343-1A patent/BR112021001343A2/pt unknown
- 2019-07-24 SG SG11202100750XA patent/SG11202100750XA/en unknown
- 2019-07-24 EP EP19840286.9A patent/EP3827084A4/en active Pending
- 2019-07-24 US US17/262,591 patent/US20210292761A1/en active Pending
- 2019-07-24 KR KR1020217005234A patent/KR102950624B1/ko active Active
- 2019-07-24 CN CN201980051856.2A patent/CN112567038A/zh active Pending
- 2019-07-24 JP JP2021504230A patent/JP2021531022A/ja not_active Withdrawn
- 2019-07-24 CA CA3107683A patent/CA3107683A1/en active Pending
- 2019-07-24 AU AU2019312269A patent/AU2019312269A1/en not_active Abandoned
-
2021
- 2021-01-24 IL IL280354A patent/IL280354A/en unknown
-
2024
- 2024-09-13 JP JP2024159028A patent/JP2024169484A/ja active Pending
-
2026
- 2026-02-19 AU AU2026201251A patent/AU2026201251A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| SG11202100750XA (en) | 2021-02-25 |
| WO2020023655A1 (en) | 2020-01-30 |
| US20210292761A1 (en) | 2021-09-23 |
| EP3827084A1 (en) | 2021-06-02 |
| KR20210039401A (ko) | 2021-04-09 |
| JP2021531022A (ja) | 2021-11-18 |
| IL280354A (en) | 2021-03-25 |
| KR102950624B1 (ko) | 2026-04-10 |
| AU2026201251A1 (en) | 2026-03-12 |
| EP3827084A4 (en) | 2023-03-15 |
| BR112021001343A2 (pt) | 2021-05-04 |
| AU2019312269A1 (en) | 2021-03-04 |
| CA3107683A1 (en) | 2020-01-30 |
| CN112567038A (zh) | 2021-03-26 |
| JP2024169484A (ja) | 2024-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2021000965A (es) | Composiciones que comprenden polirribonucleotidos circulares y usos de estas. | |
| WO2020198403A3 (en) | Compositions comprising modified circular polyribonucleotides and uses thereof | |
| MX2023011657A (es) | Composiciones que comprenden curones y usos de los mismos. | |
| MX2020006150A (es) | Composiciones que comprenden polirribonucleotidos circulares y usos de las mismas. | |
| EA201891083A1 (ru) | Составы антител к cd38 для подкожного введения и их применение | |
| PH12019501824A1 (en) | Anti-gprc5d antibody and molecule comprising the antibody | |
| MX2023010042A (es) | Polinucleotidos moduladores. | |
| MX2022004304A (es) | Agentes inductores de apoptosis. | |
| MX2019001313A (es) | Composiciones farmaceuticas. | |
| MX2021015761A (es) | Polipeptidos. | |
| MX2022001146A (es) | Formulaciones de anticuerpos anti-pvrig y sus usos. | |
| EP4279071A3 (en) | Novel cannabinoid formulations | |
| PH12019501872A1 (en) | Anti-tryptase antibodies, compositions thereof, and uses thereof | |
| PH12021550705A1 (en) | Stable semaglutide compositions and uses thereof | |
| EA201790650A1 (ru) | Лекарственная форма и способы применения абиратерона ацетата | |
| MX2019002057A (es) | Formas solidas de mesilato de cenicriviroc y procesos para elaborar formas sólidas de mesilato de cenicriviroc. | |
| WO2018226992A8 (en) | Tau aggregation inhibitors | |
| MX2019005855A (es) | Formulaciones que se pueden pulverizar. | |
| PH12016501686A1 (en) | Pharmaceutical compositions of sitagliptin | |
| EA201792262A1 (ru) | Пироглутамат вортиоксетина | |
| IN2014CH00840A (https=) | ||
| PH12020551618A1 (en) | Erenumab compositions and uses thereof | |
| JOP20200126A1 (ar) | طرق استخدام وتركيبات تحتوي على دولاجلوتيد | |
| MX2020013389A (es) | Composiciones de terlipresina y usos de las mismas. | |
| EP4582145A3 (en) | Solid state forms of ixazomib citrate |